Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP)

AIM: The aim of this study was to describe the testing rate and frequency of molecular alterations observed in the Lung Cancer Biomarker Testing Registry (LungPath). METHODS: A descriptive study of NSCLC biomarker determinations collected from March 2018 to January 2019, from 38 Spanish hospitals, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Salas, Clara, Martín-López, Javier, Martínez-Pozo, Antonio, Hernández-Iglesias, Teresa, Carcedo, David, Ruiz de Alda, Lucia, García, J Francisco, Rojo, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862081/
https://www.ncbi.nlm.nih.gov/pubmed/33722840
http://dx.doi.org/10.1136/jclinpath-2020-207280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862081/
https://www.ncbi.nlm.nih.gov/pubmed/33722840
http://dx.doi.org/10.1136/jclinpath-2020-207280

Ejemplares similares